Literature DB >> 22754073

Evaluation of the sedative and anticonvulsant properties of three Cameroonian plants.

Fleur Clarisse Moto Okomolo1, Joseph Tanyi Mbafor, Elisabeth Ngo Bum, Nadège Kouemou, Antoine Kavaye Kandeda, Emmanuel Talla, Théophile Dimo, Alice Rakotonirira, Silvère Vincent Rakotonirira.   

Abstract

Millettia thonningii, Ocinum sanctum and Securitaca longepedunculaca are used in traditional medicine in Cameroon to treat epilepsy, insomnia and headaches. Animal models of epilepsy (maximal electroshock (MES), n-methyl-d-aspartate (NMDA), pentylenetetrazol (PTZ), isonicotinic hydrazide acid (INH), picrotoxine (PIC) and strychnine (STR)-induced convulsions or turning behavior were used to evaluate anticonvulsant activity while diazepam-induced sleep test was used to evaluate sedative activity of the plants. Four doses of extracts were used for each plant (100, 200, 500 and 1000 mg/kg). At a dose of 1000 mg/kg, Millettia thonningii protected 60 and 90% of mice against MES and PTZ-induced convulsions, respectively. At the same dose, Millettia thonningii also protected 80% of mice against NMDA-induced turning behavior. At a dose of 1000 mg/kg, Ocinum sanctum provided complete protection against MES, PIC and STR- induced convulsions and 83.3% of protection in PTZ test. Securitaca longepedunculata completely protected (100%) mice in PIC test at a dose of 200 mg/kg, in MES test at a dose of 500 mg/kg and in PTZ test at a dose of 1000 mg/kg. 66.7% of mice were protected against STR-induced convulsions. All the three plants showed also sedative properties for they increased significantly and in a dose dependent manner the total sleep time induced by diazepam. The total sleep time of the control groups was multiplied by a factor of 3 at least by each extract. The presence of sedative and anticonvulsant activity in the three plants could explain their use in traditional medicine in the treatment of epilepsy and insomnia in Cameroon.

Entities:  

Keywords:  Epilepsy; Insomnia; Traditional medicine

Mesh:

Substances:

Year:  2011        PMID: 22754073      PMCID: PMC3252709          DOI: 10.4314/ajtcam.v8i5S.24

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  34 in total

1.  Anticonvulsant, anxiolytic and sedative activities of the aqueous root extract of Securidaca longepedunculata Fresen.

Authors:  O O Adeyemi; A J Akindele; O K Yemitan; F R Aigbe; F I Fagbo
Journal:  J Ethnopharmacol       Date:  2010-05-06       Impact factor: 4.360

2.  Constituents of Ocimum sanctum with antistress activity.

Authors:  Prasoon Gupta; Dinesh Kumar Yadav; Kiran Babu Siripurapu; Guatam Palit; Rakesh Maurya
Journal:  J Nat Prod       Date:  2007-09-13       Impact factor: 4.050

3.  Identification of methyl salicylate as the principal volatile component in the methanol extract of root bark of Securidaca longepedunculata Fers.

Authors:  T K Jayasekara; P C Stevenson; S R Belmain; D I Farman; D R Hall
Journal:  J Mass Spectrom       Date:  2002-06       Impact factor: 1.982

4.  Novel xanthones from Securidaca longepedunculata with activity against erectile dysfunction.

Authors:  J J Marion Meyer; N C Rakuambo; A A Hussein
Journal:  J Ethnopharmacol       Date:  2008-06-27       Impact factor: 4.360

5.  Anticonvulsant activity of Mimosa pudica decoction.

Authors:  E Ngo Bum; D L Dawack; M Schmutz; A Rakotonirina; S V Rakotonirina; C Portet; A Jeker; H-R Olpe; P Herrling
Journal:  Fitoterapia       Date:  2004-06       Impact factor: 2.882

6.  CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

Authors:  J Lehmann; A J Hutchison; S E McPherson; C Mondadori; M Schmutz; C M Sinton; C Tsai; D E Murphy; D J Steel; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

7.  Analgesic, anti-inflammatory and hypoglycaemic effects of Securidaca longepedunculata (Fresen.) [Polygalaceae] root-bark aqueous extract.

Authors:  J A O Ojewole
Journal:  Inflammopharmacology       Date:  2008-08       Impact factor: 4.473

8.  The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.

Authors:  M Schmutz; C Portet; A Jeker; K Klebs; A Vassout; H Allgeier; R Heckendorn; G E Fagg; H R Olpe; H van Riezen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

9.  CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.

Authors:  J Davies; R H Evans; P L Herrling; A W Jones; H J Olverman; P Pook; J C Watkins
Journal:  Brain Res       Date:  1986-09-10       Impact factor: 3.252

10.  Evaluation of the anxiolytic effect of Nepeta persica Boiss. in mice.

Authors:  M Rabbani; S E Sajjadi; A Mohammadi
Journal:  Evid Based Complement Alternat Med       Date:  2008-06       Impact factor: 2.629

View more
  3 in total

1.  Temperament determination for melatonin: a bridge from Iranian traditional to modern sleep medicine.

Authors:  Mohammad B Minae; Seyedshahin Soltani; Mehdi Besharat; Foruzan Karimi; Esmaeil Nazem
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

2.  Medicinal Plants Used for Neuropsychiatric Disorders Treatment in the Hauts Bassins Region of Burkina Faso.

Authors:  Prosper T Kinda; Patrice Zerbo; Samson Guenné; Moussa Compaoré; Alin Ciobica; Martin Kiendrebeogo
Journal:  Medicines (Basel)       Date:  2017-05-19

Review 3.  The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature.

Authors:  Negar Jamshidi; Marc M Cohen
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-16       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.